PO.5.105 The effect of belimumab on extra-renal outcomes: results from the phase 3, randomised, placebo-controlled, 104-week bliss-ln study in patients with active lupus nephritis

Autor:	J Weinmann-Menke, M Okada, C Arriens, A Jones-Leone, RA Levy, JA Gilbride, R Furie, N Yang
Rok vydání:	2022
Zdroj:	Friday 07 October 2022 from 13:00 to 14:10.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::86499f22e44c5e60459d826ee06ac6d7 https://doi.org/10.1136/lupus-2022-elm2022.129 Zobrazit plný text záznamu